Physician profile
Mohit Bansal
NPI 1942422852
$1,963.77
in general payments reported to CMS, 2019-2025
31 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $74.28 · 2021: $216 · 2022: $353 · 2023: $838 · 2024: $328 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,320.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $221.29 | 2022-2023 | Ozempic, Rybelsus, Wegovy |
| Pulmonx Corporation | $170.03 | 2023-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Zimmer Biomet Holdings, INC. | $144.00 | 2021 | |
| Lilly USA, LLC | $143.53 | 2022-2023 | Mounjaro, Jardiance, Lyumjev |
| Alphatec Spine, INC | $130.82 | 2024 | Battalion Plif - Ps |
| Glaxosmithkline, LLC. | $110.46 | 2022-2023 | Trelegy Ellipta, Arexvy, Shingrix |
| Esperion Therapeutics, INC. | $105.11 | 2021-2023 | Nexletol |
| Novartis Pharmaceuticals Corporation | $99.49 | 2023-2024 | |
| Silk Road Medical, INC. | $97.31 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Amgen INC. | $84.11 | 2022-2023 | Repatha, Otezla |
| Abbvie INC. | $81.74 | 2022-2023 | Ubrelvy, Vraylar |
| Abbott Laboratories | $80.41 | 2023-2025 | Freestyle Libre 3 |
| Intuitive Surgical, INC. | $76.92 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $74.28 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.47 | 2021-2023 | Tradjenta, Synjardy |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $36.80 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $30.90 | 2022 | |
| Exact Sciences Corporation | $26.59 | 2023 | Cologuard Collection Kit |
| Axsome Therapeutics, INC. | $24.74 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.63 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $18.45 | 2023 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.22 | 2023 | Xifaxan, Trulance |
| Sunovion Pharmaceuticals INC. | $17.02 | 2021 | |
| Sumitomo Pharma America, INC. | $16.44 | 2023 | Gemtesa |
| Boston Scientific Corporation | $15.71 | 2023 | |
| Philips North America LLC | $14.51 | 2023 | |
| Xeris Pharmaceuticals, INC. | $13.64 | 2023 | Recorlev |
| Janssen Pharmaceuticals, INC | $13.05 | 2023 | Xarelto |
| Cequr Corporation | $12.10 | 2023 | Cequr Simplicity |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohit Bansal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.